Article
Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2.
Journal of neurology, neurosurgery, and psychiatry - 1 Nov 2013
Gonzalez Michael, McLaughlin Heather, Houlden Henry, Guo Min, Yo-Tsen Liu, Hadjivassilious Marios, Speziani Fiorella, Yang Xiang-Lei, Antonellis Anthony, Reilly Mary M, Züchner Stephan
Abstract excerpt
Charcot-Marie-Tooth (CMT) disease is a genetically heterogeneous condition with >50 genes now being identified. Thanks to new technological developments, namely, exome sequencing, the ability to identify additional rare genes in CMT has been drastically improved. Here we present data suggesting that MARS is a very rare novel cause of late-onset CMT2. This is supported by strong functional and evolutionary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
